Ida Hyllen Klæstrup

Ida Hyllen Klæstrup

Auto-generated profile, based on publicly available information

Ida Hyllen Klæstrup

Department of Biomedicine, Health Faculty, Aarhus University, Aarhus DK8000, Denmark

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2022 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
IKIda Hyllen Klæstrup
Ida Hyllen Klæstrup
MJMie Kristine Just
Mie Kristine Just
KHKarina Lassen Holm
Karina Lassen Holm
AAAage Kristian Olsen Alstrup
Aage Kristian Olsen Alstrup
MRMarina Romero-Ramos
Marina Romero-Ramos
NBNathalie Van Den Berge
Nathalie Van Den Berge
Aging is the biggest risk factor for developing Parkinson's disease (PD), the second most common neurodegenerative disorder. Several animal models have been developed to explore the pathophysiology underlying neurodegeneration and the initiation and spread of alpha-synuclein-related PD pathology, and to investigate biomarkers and therapeutic strategies. However, bench-to-bedside translation of preclinical findings remains suboptimal and successful disease-modifying treatments remain to be discovered. Despite aging being the main risk factor for developing idiopathic PD, most studies employ young animals in their experimental set-up, hereby ignoring age-related cellular and molecular mechanisms at play. Consequently, studies in young animals may not be an accurate reflection of human PD, limiting translational outcomes. Recently, it has been shown that aged animals in PD research demonstrate a higher susceptibility to developing pathology and neurodegeneration, and present with a more disseminated and accelerated disease course, compared to young animals. Here we review recent advances in the investigation of the role of aging in preclinical PD research, including challenges related to aged animal models that are limiting widespread use. Overall, current findings indicate that the use of aged animals may be required to account for age-related interactions in PD pathophysiology. Thus, although the use of older animals has disadvantages, a model that better represents clinical disease within the elderly would be more beneficial in the long run, as it will increase translational value and minimize the risk of therapies failing during clinical studies. Furthermore, we provide recommendations to manage the challenges related to aged animal models.

2 June 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
IKIda H. Klæstrup
Ida H. Klæstrup
LRLine Reinert
Line Reinert
SFSara A. Ferreira
Sara A. Ferreira
JLJohanne Lauritsen
Johanne Lauritsen
GTGitte U. Toft
Gitte U. Toft
MRMarina Romero-Ramos
Marina Romero-Ramos
Microglia response is proposed to be relevant in the neurogenerative process associated with alpha-synuclein (α-syn) pathology in Parkinson’s disease (PD). STING is a protein related to the immune sensing of DNA and autophagy, and it has been proposed to be involved in PD neurodegeneration. To investigate this, we injected 10 µg of murine pre-formed fibrils (PFFs) of α-syn (or monomeric and PBS as controls) into the striatum of wild-type (WT) and STING gt/gt mice, which lack functional STING. We examined motor behavior and brain pathology at 1- and 6-months post-injection. STING gt/gt mice showed more motor changes associated with PFF injection than WT mice. STING gt/gt mice had a differential immune response to PFF with early and sustained increased microglia numbers and higher macrophagic CD68 response, but milder changes in the expression of immune-relevant markers such as TLR2, TLR4, IL1b, and TREM2. However, the lack of STING did not induce changes in the extent of α-syn pathology nor the p62 accumulation seen in the model. Altogether, this resulted in a faster but similar degree of nigrostriatal dopaminergic degeneration after 6 months. Therefore, the data do not support a necessary role for STING in the α-syn induced nigral neuronal loss in the PFF-PD mouse model used here. However, the results suggest a functional relevance for STING in the brain response to the excess and aggregation of amylogenic proteins such as α-syn that can contribute to symptomatic changes.

18 October 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
SFSara A. Ferreira
Sara A. Ferreira
CLConghui Li
Conghui Li
IKIda H. Klæstrup
Ida H. Klæstrup
ZVZagorka Vitic
Zagorka Vitic
RRRikke K. Rasmussen
Rikke K. Rasmussen
MRMarina Romero-Ramos
Marina Romero-Ramos
Alpha-synuclein (α-syn) aggregation and immune activation represent hallmark pathological events in Parkinson’s disease (PD). The PD-associated immune response encompasses both brain and peripheral immune cells, although little is known about the immune proteins relevant for such response. We propose that the upregulation of CD163 observed in blood monocytes and in the responsive microglia in the PD patients is a protective mechanism in the disease. To investigate this, we used the PD model based on intrastriatal injections of murine α-syn pre-formed fibrils (PFF) in CD163 knockout (KO) mice and wild-type littermates. CD163KO females revealed an impaired and differential early immune response to α-syn pathology as revealed by immunohistochemical and transcriptomic analysis. After 6 months, CD163KO females showed an exacerbated immune response and α-syn pathology, which ultimately led to dopaminergic neurodegeneration of greater magnitude. These findings support a novel, sex-dimorphic neuroprotective role for CD163 during α-syn-induced neurodegeneration.